FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
ANI Pharma (NASDAQ: ANIP) reported Q3 EPS of $1.09, $0.01 better than the analyst estimate of $1.08. Revenue for the quarter came in at $38.5 million versus the consensus estimate of $34.34 million.
GUIDANCE:
ANI Pharma sees FY2016 EPS of $4.00-$4.25, versus the consensus... More

